Breaking News

BMS Appoints Discovery and Clinical Pharmacology SVP

January 18, 2013

Burgess brings extensive industry and leadership experience

Mike Burgess M.D., Ph.D. has been appointed senior vice president of Discovery Medicine and Clinical Pharmacology at Bristol-Myers Squibb. He reports to Francis Cuss, senior vice president, Research, R&D, and will be a member of the Research Senior Leadership Team.
 
Prior to joining the company, Dr. Burgess was interim head of Hoffman La-Roche’s Pharma Research and Early Development organization, and previously led the Oncology Discovery and Translational Area. Before joining Roche, Dr. Burgess was a medical fellow at Eli Lilly and Co.
 
“As a physician scientist with a Ph.D. in molecular biology, clinical experience in pediatrics and pediatric oncology, and extensive pharmaceutical industry and leadership experience, I believe Mike will be an important addition to our research and development organization,” said Dr. Cuss. “Mike’s broad clinical expertise, cross-therapeutic global team leadership and proven operational excellence will enable Bristol-Myers Squibb to continue to execute its strategy of ensuring sustainable delivery of an innovative pipeline of new medicines for patients.”
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks